Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia

Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia

Biosimilars are safe and effective treatments for chronic diseases such as cancer and rheumatoid arthritis. The Saudi Food and Drug Authority (SFDA) manages the quality and registration of biosimilars in the Kingdom of Saudi Arabia. However, disparities among regulatory authorities, such as the abse...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Alqahtani, Ahmed Al-jedai, Albert Wertheimer
Format: Article
Language:English
Published: University of Minnesota Libraries Publishing 2024-11-01
Series:INNOVATIONS in Pharmacy
Subjects:
Biosimilars
intention
perceptions
interchangeability
Online Access:https://pubs.lib.umn.edu/index.php/innovations/article/view/6371
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items